Get started
Author

Zahary Krastev

Observed names: Krastev, Zahary, Zaharyi Krastev
OpenAlex ID: A5110068416
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
2008 · Patrick Marcellin, E. Jenny Heathcote, et al. · New England Journal of Medicine · 1,168
PDF
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
2010 · E. Jenny Heathcote, Patrick Marcellin, et al. · Gastroenterology · 455
PDF
Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
2014 · Maria Buti, Naoky Tsai, et al. · Digestive Diseases and Sciences · 297
PDF
Efficacy of Tenofovir Disoproxil Fumarate At 240 Weeks in Patients With Chronic Hepatitis B With High Baseline Viral Load
2013 · Stuart C. Gordon, Zahary Krastev, et al. · Hepatology · 115
PDF
Randomized, Double-Blind Study of Emtricitabine (FTC) plus Clevudine versus FTC Alone in Treatment of Chronic Hepatitis B
2006 · Seng Gee Lim, Zahary Krastev, et al. · Antimicrobial Agents and Chemotherapy · 47
Alpha-2 Macroglobulin Is The Simplest Serum Biomarker For Liver Fibrosis And Fibrogenesis In Chronic Hepatitis C
2015 · Evelina Atanasova, Fani Martinova, et al. · Journal of Medical and Dental Practice · 8
PDF
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)
2014 · Scott Fung, Stuart C. Gordon, et al. · Liver International · 7
Sa1046 Efficacy of 5 Years of Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B Patients With High Viral Load (HBV DNA =9 Log10 Copies/Ml)
2012 · Stuart C. Gordon, Patrick Marcellin, et al. · Gastroenterology · 2
Oral Cavity and Systemic Diseases—Langerhans Cell Histiocytosis
2012 · Assya Krasteva, Elena Obreshkova, et al. · Biotechnology & Biotechnological Equipment · 2
SELECT-2 Clinical Trial Assessing the Efficacy and Saftey of Controlled-Release Interferon Alpha-2B (CR2b)+Ribavirin (RBV) Versus Pegylated Interferon Alpha-2B (Peg2b)+RBV in Treatment-NaïVE Genotype-1 (G1) Hepatitis C
2011 · Zobair M. Younossi, Eric J. Lawitz, et al. · Gastroenterology · 2
Safety and Efficacy of Iron Isomaltoside in Two Cases with Liver Cirrhosis and Iron Deficiency Anemia
2015 · Liuben Milatchkov, Tanya Petkova, et al. · Journal of Medical and Dental Practice · 1
PDF
Association between ALT flares and HBeAg loss and HBsAg decline in Patients with Chronic Hepatitis B during treatment with Tenofovir Disoproxil Fumarate or Adefovir Dipivoxil
2015 · GÜREL, SELİM, Dusheiko, Geoffrey M., et al. · Bursa Uludag University - AVESIS
Sa1070 Depression is as Early Complication of HCV Treatment: Results From EMPOWER (a Randomized, Open-Label 12-Week Comparison in 133 Patients)
2012 · Walker A. Long, Dimitar V. Takov, et al. · Gastroenterology
Oral Cavity and Systemic Diseases—Gastroesophageal Reflux Disease
2012 · Assya Krasteva, Vladimir Panov, et al. · Biotechnology & Biotechnological Equipment
Continued Efficacy and Safety Through 4 Years of Tenofovir Disoproxil Fumarate (tdf) Treatment in Hbeag-negative Patients With Chronic Hepatitis B (study 102): Preliminary Analysis
2010 · GÜREL, SELİM, Dusheiko, Geoffrey M., et al. · Bursa Uludag University - AVESIS
Three Years of Tenofovir Disoproxil Fumarate (tdf) Treatment in Hbeag-negative Patients With Chronic Hepatitis B (study 102); Preliminary Analysis
2009 · GÜREL, SELİM, Rousseau, Franck, et al. · Bursa Uludag University - AVESIS
W1814 Safety and Tolerability of 96 Weeks of Tenofovir Disoproxil Fumarate (TDF) Treatment in HBeAg Negative and Positive Patients Infected with Chronic Hepatitis B (CHB)
2009 · Ira M. Jacobson, Patrick Marcellin, et al. · Gastroenterology
Two Year Tenofovir Disoproxil Fumarate (tdf) Treatment and Adefovir Dipivoxil (adv) Switch Data in Hbeag-negative Patients With Chronic Hepatitis B (study 102), Preliminary Analysis
2008 · GÜREL, SELİM, Dusheiko, Geoff, et al. · Bursa Uludag University - AVESIS
Antiviral response and resistance surveillance for HBeAgnegative patients enrolled in a combination study evaluatingemtricitabine plus clevudine versus emtricitabine monotherapyfor the treatment of chronic hepatitis B infection.
2005 · A. Snow, Zahary Krastev, et al. · Hepatology
Works count: 19
Citation count: 2,104
H-index: 7
I10-index: 5
Year
Topic
Type